至少有12家美国制药公司正在研发防止或减缓中老年人记忆力衰退的药物,目前这项工作已进入最后阶段。现年72岁的纽约哥伦比亚大学教授坎戴尔长期研究记忆力减退问题,并于2000年获得诺贝尔奖。据称,他已发现一些基因与丧失记忆力有关,并研发出可以扭转记忆力衰退的药物,这些药在一年内将进入临床试验阶段,在3至5年内可上市。 At least 12 U.S. pharmaceutical companies are developing drugs to prevent or slow memory loss in the elderly, which is in its final stages. Kandell, a 72-year-old professor at Columbia University in New York City, has long studied the problem of memory loss and won the Nobel Prize in 2000. Allegedly, he has discovered that some genes are associated with memory loss and have developed drugs that can reverse the decline in memory that will enter clinical trials within a year and will be available in three to five years.